Prime Medicine
Biotech · Public
Prime editing platform for precise in vivo gene correction
primemedicine.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1421 | NEUMEDICINES, INC. | — | — |
| 1422 | Rectify Pharmaceuticals LLC | — | — |
| 1423 | MOLECULAR THERANOSTICS, LLC | — | — |
| 1424 | Prime Medicine | — | — |
| 1425 | Guide Star Biosciences, Inc. | — | $925K |
| 1426 | Gamma Therapeutics, Inc. | — | — |
| 1427 | Solutions BioMed LLC | — | $5.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Genome Editing Compositions and Methods for Treatment of Friedreich's Ataxiaapplication
- Split Prime Editorsapplication
- Genome Editing Compositions And Methods For Treatment Of Fuchs Endothelial Corneal Dystrophyapplication
- Modified Prime Editing Guide Rnasapplication
- Methods And Compositions For Inhibiting Mismatch Repairapplication
- Genome Editing Compositions And Methods For Treatment Of Chronic Granulomatous Diseaseapplication
- Genome Editing Compositions And Methods For Treatment Of Glycogen Storage Disease Type 1Bapplication
- Genome Editing Compositions And Methods For Treatment Of Fragile X Syndromeapplication
- Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosisapplication
- Genome Editing Compositions And Method For Treatment Of Retinitis Pigmentosaapplication
- Genome Editing Compositions And Methods For Treatment Of Usher Syndrome Type 3application
- Genome Editing Compositions And Methods For Treatment Of Fanconi Anemiaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.